U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(57)
(67)
(184)
(230)
(500)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(427)
(406)
(97)
(156)
(103)
(110)
(97)
(92)
(119)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(56)
(63)
(187)
(223)
(500)
(663)
(656)
(409)
(483)
(558)
(231)
(311)
(436)
(413)
(91)
(148)
(100)
(104)
(102)
(92)
(120)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(161)
(151)
(137)
(163)
(169)
(155)
(160)
(161)
(157)
(164)
(165)
(157)
(165)
(157)
(174)
(142)
(156)
(159)
(135)
(156)
(141)
(142)
(141)
(137)
(138)
(142)
(131)
(162)
(144)
(136)
(152)
(152)
(177)
(206)
(197)
(165)
(187)
(179)
(201)
(205)
(202)
(223)
(226)
(232)
(221)
(225)
(252)
(252)
(278)
0 of 56
(2)
(1)
(4)
(431)
(108)
(406)
(13)
(8559)
0 of 8
(16)
(34)
(2)
(6)
(39)
(4)
(1)
(1)
0 of 8
(10)
(18)
(10)
(9)
(11)
(10)
(25)
(11)
(7)
(27)
(21)
(42)
(7)
(58)
(7)
(23)
(13)
(38)
(10)
(10)
(50)
(8)
(1237)
(23)
(1293)
(32)
(71)
(91)
(27)
(16)
(7)
(128)
(70)
(790)
(24)
(198)
(39)
(61)
(38)
(19)
(26)
(20)
(15)
(26)
(9)
(11)
(17)
(10)
(7)
(49)
(11)
(8)
(224)
(17)
(17)
(8)
(181)
(137)
(130)
(33)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(30)
(18)
(10)
(7)
(18)
(99)
(13)
(12)
(36)
(8)
(18)
(12)
(7)
(13)
(11)
(30)
(10)
(28)
(9)
(9)
(15)
(21)
(8)
(17)
(7)
(8)
(31)
(77)
(60)
(8)
(7)
(14)
(12)
(13)
(15)
(19)
(11)
(85)
(13)
(14)
(31)
(13)
(30)
(14)
(12)
(187)
(7)
(7)
(17)
(8)
(18)
(53)
(11)
(10)
(8)
(24)
(21)
(691)
(8)
(11)
(15)
(59)
(205)
(7)
(9)
(18)
(10)
(66)
(14)
(23)
(7)
(17)
(22)
(21)
(7)
(15)
(10)
(9)
(24)
(13)
(31)
(20)
(7)
(13)
(29)
(13)
(31)
(74)
(26)
(20)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(941)
(9)
(14)
(14)
(740)
(35)
(103)
(10)
(51)
(10)
(20)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(20)
(21)
(19)
(20)
(16)
(177)
(81)
(2981)
(316)
(263)
(12)
(543)
(215)
(37)
(38)
(25)
(14)
(15)
(14)
(12)
(34)
(10)
(80)
(14)
(11)
(8)
(23)
(8)
(8)
(439)
(23)
(15)
(8)
(73)
(19)
(28)
(31)
(24)
(10)
(18)
(18)
(18)
(45)
(74)
(8)
(40)
(11)
(8)
(11)
(20)
(19)
(58)
(9)
(23)
(8)
(16)
(34)
(44)
(83)
(9)
(10)
(9)
(21)
(65)
(13)
(14)
(28)
(25)
(14)
(10)
(10)
(8)
(166)
(26)
(11)
(14)
(35)
(24)
(9)
(9)
(24)
(26)
(12)
(92)
(4171)
(642)
(34)
(12)
(17)
(14)
(11)
(10)
(12)
(13)
(9)
(28)
(16)
(19)
(8)
(12)
(27)
(17)
(46)
(20)
(28)
(36)
(10)
(20)
(21)
(8)
(8)
(8)
(66)
(91)
(9)
(25)
(27)
(13)
(21)
(22)
(8)
(39)
(56)
(69)
(21)
(15)
(149)
(16)
(14)
(8)
(12)
(32)
(19)
(19)
(16)
(22)
(10)
(11)
(144)
(45)
(32)
(9)
(41)
(15)
(32)
(660)
(26)
(9)
(56)
(14)
(130)
(9)
(18)
(62)
(10)
(10)
(30)
(11)
(10)
(13)
(21)
(8)
(15)
(23)
(111)
(23)
(1338)
(15)
(10)
(17)
(11)
(13)
(8)
(8)
(48)
(8)
(42)
(45)
(25)
(47)
(13)
(25)
(186)
(14)
(16)
(11)
(586)
(394)
(15)
(21)
(14)
(152)
(16)
(53)
(9)
(28)
(10)
(19)
(162)
(8)
(10)
(14)
(31)
(9)
(8)
(9)
(19)
(11)
(8)
(8)
(110)
(10)
(78)
(11)
(68)
(60)
(17)
(23)
(60)
(132)
(19)
(105)
(58)
(12)
(39)
(126)
(35)
(97)
(52)
(17)
(10)
(11)
(12)
(12)
(8)
(14)
(52)
(71)
(116)
(173)
(25)
(17)
(50)
(13)
(10)
(33)
(12)
(10)
(46)
(8)
(29)
(11)
(8)
(8)
(60)
(31)
(90)
(44)
(12)
(28)
(51)
(9)
(207)
(18)
(32)
(17)
(19)
(2446)
(16)
(19)
(18)
(11)
(106)
(8)
(207)
(232)
(20)
(38)
(23)
(8)
(8)
(9)
(18)
(240)
(11)
(49)
(678)
(47)
(10)
(308)
(15)
(63)
(23)
(17)
(8)
(21)
(188)
(54)
(48)
(8)
(45)
(114)
(50)
(125)
(28)
(11)
(10)
(596)
(15)
(22)
(13)
(61)
(9)
(26)
(29)
(14)
(37)
(12)
(8)
(32)
(12)
(22)
(8)
(8)
(22)
(13)
(16)
(11)
(10)
(73)
(9)
(10)
(10)
(74)
(32)
(114)
(9)
(13)
(41)
(17)
(55)
(17)
(13)
(16)
(18)
(10)
(17)
(44)
(66)
(10)
(11)
(9)
(10)
(12)
(177)
(12)
(14)
(17)
(1181)
(9)
(9)
(8)
(50)
(10)
(44)
(109)
(10)
(16)
(8)
(19)
(312)
(33)
(23)
(12)
(9)
(84)
(11)
(12)
(41)
(11)
(18)
(20)
(8)
(11)
(8)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(40)
(13)
(17)
(17)
(9)
(9)
(66)
(19)
(963)
(103)
(15)
(48)
(30)
(8)
(11)
(57)
(3831)
(11)
(9)
(9)
(29)
(8)
(22)
(16)
(16)
(15)
(17)
(10)
(8)
(13)
(8)
(11)
(18)
(9)
(14)
(15)
(9)
(16)
(41)
(43)
(20)
(10)
(27)
(11)
(12)
(10)
(15)
(243)
(18)
(22)
(36)
(8)
(15)
(113)
(10)
(257)
(611)
(72)
(11)
(23)
(17)
(8)
(11)
(15)
(9)
(10)
(10)
(301)
(12)
(11)
(8)
(14)
(12)
(11)
(20)
(10)
(10)
(16)
(13)
(13)
(22)
(10)
(10)
(65)
(10)
(9)
(10)
(9)
(19)
(12)
(9)
(144)
(18)
(15)
(8)
(33)
(144)
(22)
(11)
(171)
(10)
(8)
(8)
(70)
(30)
(25)
(21)
(343)
(24)
(115)
(36)
(11)
(8)
(84)
(34)
(14)
(8)
(10)
(21)
(29)
(20)
(16)
(1141)
(18)
(27)
(18)
(22)
(110)
(15)
(22)
(23)
(349)
(19)
(72)
(16)
(26)
(14)
(15)
(10)
(26)
(35)
(10)
(9)
(11)
(216)
(50)
(16)
(23)
(34)
(21)
(10)
(19)
(74)
(20)
(9)
(233)
(1005)
(22)
(24)
(71)
(101)
(2519)
(11)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(177)
(38)
(14)
(11)
(279)
(15)
(9)
(13)
(45)
(8)
(32)
(91)
(9)
(17)
(18)
(11)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(24)
(104)
(187)
(28)
(29)
(25)
(10)
(20)
(9)
(58)
(195)
(303)
(67)
(8)
(21)
(12)
(8)
(59)
(18)
(34)
(9)
(38)
(177)
(10)
(617)
(31)
(32)
(146)
(241)
(12)
(18)
(10)
(8)
(122)
(11)
(126)
(9)
(16)
(18)
(15)
(20)
(11)
(9)
(19)
(11)
(28)
(35)
(37)
(11)
(8)
(65)
(22)
(42)
(14)
(16)
(28)
(10)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(18)
(12)
(184)
(28)
(9)
(23)
(71)
(25)
(23)
(25)
(14)
(8)
(9)
(108)
(8)
(22)
(16)
(44)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(10)
(8)
(12)
(18)
(94)
(31)
(35)
(12)
(49)
(8)
(38)
(91)
(9)
(22)
(14)
(183)
(8)
(11)
(8)
(19)
(33)
(21)
(19)
(12)
(8)
(69)
(9)
(54)
(15)
(12)
(8)
(15)
(8)
(8)
(10)
(58)
(19)
(182)
(28)
(36)
(22)
(106)
(19)
(157)
(9)
(12)
(15)
(13)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(62)
(13)
(29)
(17)
(50)
(17)
(19)
(9)
(14)
(466)
(48)
(50)
(105)
(11)
(17)
(104)
(8)
(29)
(24)
(34)
(21)
(40)
(10)
(23)
(31)
(20)
(35)
(21)
(18)
(12)
(8)
(43)
(94)
(22)
(26)
(9)
(23)
(9)
(12)
(8)
(39)
(14)
(14)
(59)
(11)
(9)
(38)
(17)
(16)
(39)
(16)
(78)
(8)
(43)
(13)
(15)
(10)
(46)
(27)
(762)
(30)
(57)
(10)
(12)
(29)
(33)
(10)
(10)
(8)
(14)
(51)
(8)
(61)
(16)
(9)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(18)
(8)
(7)
(10)
(11)
(7)
(9)
(7)
(10)
(9)
(11)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(12)
(23)
(15)
(9)
(7)
(7)
(7)
(9)
(13)
(11)
(9)
(15)
(7)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(12)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(16)
(9)
(10)
(7)
(11)
(28)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(8)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(7)
(29)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(14)
(22)
(31)
(11)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(7)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(16)
(9)
(7)
(9)
(12)
(19)
(13)
(7)
(7)
(7)
(11)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(9)
(8)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(20)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(18)
(8)
(12)
(8)
(8)
(8)
(13)
(7)
(7)
(8)
(15)
(7)
(17)
(17)
(16)
(8)
(20)
(7)
(8)
(11)
(11)
(21)
(8)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(15)
(12)
(17)
(16)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(19)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(11)
(8)
(9)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(9)
(11)
(15)
(42)
(16)
(8)
(8)
(29)
(10)
(7)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(16)
(20)
(11)
(10)
(15)
(17)
(12)
(18)
(7)
(17)
(16)
(10)
(15)
(18)
(14)
(16)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(27)
(8)
(7)
(26)
(18)
(8)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(13)
(12)
(16)
(9)
(13)
(8)
(15)
(24)
(8)
(8)
(8)
(7)
(17)
(9)
(7)
(28)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(59)
(12)
(8)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(8)
(18)
(9)
(15)
(10)
(8)
(25)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(20)
(7)
(28)
(15)
(10)
(9)
(26)
(18)
(7)
(8)
(8)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(8)
(30)
(15)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(7)
(7)
(10)
(9)
(8)
(9)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(7)
(20)
(9)
(15)
(7)
(11)
(12)
(11)
(13)
(8)
(7)
(19)
(26)
(17)
(7)
(15)
(9)
(8)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(35)
(21)
(7)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(24)
(12)
(8)
(53)
(7)
(7)
(19)
(8)
(10)
(7)
(10)
(8)
(11)
(7)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(7)
(12)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(13)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(7)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(38)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(8)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(14)
(14)
(9)
(15)
(9)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(10)
(7)
(7)
(17)
(8)
(8)
(7)
(9)
(9)
(13)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(9)
(19)
(10)
(7)
(7)
(13)
(7)
(7)
(8)
(10)
(21)
(15)
(35)
(14)
(18)
(7)
(7)
(7)
(8)
(21)
(16)
(24)
(24)
(18)
(8)
(7)
(18)
(12)
(7)
(7)
(13)
(25)
(7)
(8)
(12)
(11)
(19)
(7)
(27)
(18)
(10)
(10)
(8)
(12)
(7)
(7)
(7)
(10)
(7)
(7)
(10)
(16)
(12)
(10)
(7)
(18)
(7)
(25)
(10)
(15)
(10)
(18)
(24)
(13)
(16)
(9)
(19)
(13)
(26)
(16)
(18)
(8)
(10)
(8)
(10)
(14)
(7)
(10)
(7)
(13)
(7)
(7)
(11)
(17)
(7)
(15)
(13)
(13)
(13)
(8)
(33)
(8)
(11)
(11)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(23)
(8)
(11)
(14)
(8)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(13)
(10)
(16)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(12)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(8)
(13)
(16)
(9)
(12)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(73)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(11)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(12)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(33)
(9)
(16)
(10)
(10)
(10)
(12)
(8)
(9)
(33)
(16)
(8)
(10)
(8)
(11)
(13)
(14)
(21)
(10)
(15)
(8)
(8)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(12)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(21)
(13)
(21)
(23)
(25)
(8)
(9)
(11)
(11)
(15)
(10)
(13)
(10)
(9)
(19)
(14)
(10)
(15)
(28)
0 of 1000
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(9)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(16)
(1)
(1)
(14)
(7)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(33)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(1)
(4)
(3)
(5)
(6)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(4)
(7)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(12)
(1)
(3)
(1)
(3)
(1)
(1)
(125)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3943)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(3)
(1)
(3)
(1)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(7)
(2)
(1)
(1)
(2)
(1)
(65)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(6)
(5)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(3)
(21)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(425)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(5)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(2)
(2)
(3)
(3)
(9)
(2)
(2)
(2)
(2)
(2)
(9)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(2)
(7)
(12)
(4)
(2)
(3)
(4)
(2)
(3)
(4)
(2)
(5)
(4)
(7)
(2)
(5)
(7)
(2)
(9)
(4)
(2)
(4)
(9)
(2)
(2)
(2)
(2)
(4)
(2)
(8)
(9)
(3)
(3)
(2)
(2)
(5)
(2)
(5)
(4)
(3)
(2)
(9)
(4)
(4)
(3)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(2)
(11)
(3)
(2)
(2)
(2)
(3)
(2)
(10)
(2)
(4)
(8)
(2)
(15)
(2)
(2)
(3)
(20)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(24)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(3)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(3)
(9)
(5)
(9)
(50)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(2)
(2)
(3)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(7)
(5)
(3)
(3)
(2)
(5)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(7)
(2)
(2)
(3)
(3)
(3)
(6)
(2)
(3)
(3)
(10)
(2)
(16)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(4)
(13)
(17)
(2)
(2)
(149)
(24)
(2)
(2)
(4)
(8)
(7)
(11)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(22)
(2)
(2)
(6)
(3)
(9)
(4)
(2)
(3)
(15)
(3)
(4)
(3)
(6)
(8)
(15)
(2)
(23)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(2)
(2)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(125)
(2)
(3)
(2)
(5)
(7)
(2)
(3)
(2)
(4)
(6)
(3)
(3)
(2)
(3)
(2)
(6)
(10)
(12)
(2)
(3)
(3)
(4)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(2)
(2)
(2)
(4)
(13)
(4)
(2)
(3)
(2)
(9)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(4)
(3)
(3)
(3)
(4)
(2)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(14)
(7)
(2)
(2)
(3)
(3)
(2)
(2)
(7)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(3)
(3)
(2)
(93)
(6)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(4)
(3)
(3)
(6)
(2)
(4)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(3)
(2)
(5)
(4)
(2)
(2)
(2)
(2)
(4)
(4)
(2)
(3)
(15)
(3)
(2)
(2)
(14)
(2)
(5)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(8)
(2)
(4)
(2)
(2)
(3)
(3)
(7)
(4)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(2)
(2)
0 of 1000
(2)
(1)
(111)
(8)
(1)
(2855)
(2004)
(4)
(13)
(34)
(81)
(3)
(1)
(1)
(2)
(3)
(19)
(1)
(46)
(4166)
(2)
(4)
(2)
0 of 23
(1)
(15)
(33)
(8)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(2)
(180)
(1)
(114)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(168)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(1)
(2)
(1)
(23)
(2)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(1)
(16)
(1)
(3)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(871)
(2)
(1)
(11)
(1)
(3)
(6)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(14)
(3)
(4)
(53)
(1)
(1)
(1)
(1)
(8)
(17)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(266)
(1)
(7)
(1)
(1)
(3)
(201)
(2)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(1)
(17)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(177)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(4)
(1)
(1)
(68)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(39)
(2)
(1)
(1)
(5)
(3)
(12)
(316)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(468)
(3)
(6)
(42)
(1)
(3)
(12)
(5)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(18)
(1)
(112)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(1)
(3)
(76)
(307)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(213)
(18)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(4)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(3)
(1)
(4)
(5)
(96)
(1)
(2)
(209)
(1)
(3)
(2)
(2)
(3)
(1)
(1)
(127)
(9)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(204)
(1)
(1)
(272)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(265)
(12)
(5)
(3)
(11)
(1)
(8)
(1)
(3)
(1)
(1)
(3)
(1)
(306)
(1)
(131)
(1)
(163)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(9)
(2)
(27)
(34)
(1)
(1)
(3)
(18)
(60)
(1)
(237)
(2)
(1)
(187)
(2)
(1)
(5)
(1)
(500)
(6)
(1)
(7)
(1)
(1)
(156)
(5)
(1)
(16)
(2)
(1)
(6)
(3)
(2)
(1)
(1)
(3)
(3)
(5)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(45)
(4)
(1)
(1)
(2)
(1)
(10)
(8)
(5)
(2)
(1)
(1)
(1)
(57)
(72)
(80)
(241)
(256)
(318)
(52)
(45)
(51)
(88)
(1)
(1)
(1)
(1)
(1)
(558)
(114)
(1)
(1)
(4)
(10)
(1)
(1)
(267)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(7)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(301)
(1)
(1)
(13)
(10)
(2)
(1)
(27)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(154)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(11)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(13)
(11)
(1)
(2)
(1)
(117)
(46)
(4)
(8)
(2)
(1)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(185)
(1)
(1)
(481)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(130)
(1)
(11)
(27)
(1)
(1)
(1)
(67)
(7028)
(1)
(11)
(1)
(5)
(154)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(3)
(31)
(1)
(4)
(2)
(4)
(215)
(1)
(1)
(30)
(2)
(1)
(390)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(256)
(1)
(1)
(3)
(1)
(1)
(195)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(8)
(9)
(1)
(2)
(1)
0 of 775
(1)
(55)
(9)
(1)
(2)
(25)
(295)
(2)
(2)
(2)
(3)
(1)
(5)
(27)
(1)
(3)
(5)
(14)
(60)
(10)
(1)
(2)
(4)
(1)
(787)
(2802)
(3)
(5)
(5)
(37)
(1)
(16)
(1)
(7)
(3)
(16)
(3)
(27)
(1)
(108)
(2)
(383)
(51)
(1)
(1)
(1)
(1)
(2004)
(1)
(4)
(1)
(8)
(344)
(4)
(3)
(48)
(3)
0 of 57
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
0 of 794
(82)
(4)
(1)
(6)
0 of 4
Showing 921 - 940 of 9550 results
  • MMWR Morbidity and Mortality Weekly Report Vol 71 No 11 March 18 2022
    MMWR. Morbidity and Mortality Weekly Report, Vol. 71, No. 11, March 18, 2022
    Centers for Disease Control and Prevention (U.S.)
    03/18/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Tobacco Product Use Among Adults — U.S. 2020 / Monica E. Cornelius; Caitlin G. Loretan; Teresa W. Wang; Ahmed Jamal et al.-- Progress Toward Achieving and Sustaining Maternal and Neonatal TetanuElimination — Worldwide, 2000–2020 / Florence A. Kanu; Nasir Yusuf; Modibo Kassogue; Bilal Ahmed; Rania A. Tohme -- Reported Cases of End-Stage Kidney Disea ...
    Public Domain
  • Hospitalization of Infants and Children Aged 04 Years with LaboratoryConfirmed COVID19 COVIDNET 14 States March 2020February 2022
    Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
    Marks, Kristin J. ;
    Whitaker, Michael
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The B.1.1.529 (Omicron) Variants of SARS-CoV-2, the Virus that causes COVID-19, has been the predominant circulating Variants in the U.S. since late December 2021.* Coinciding with increased Omicron circulation, COVID-19-associated hospitalization rates increased rapidly among infants and children aged 0-4 years, a group not yet eligible for vaccin ...
    Supporting Files Public Domain
  • COVID19 MRNA Vaccines Help Protect Against the Most Serious COVID19 Outcomes Even During Omicron
    COVID-19 MRNA Vaccines Help Protect Against the Most Serious COVID-19 Outcomes, Even During Omicron
    Centers for Disease Control and Prevention (U.S.)
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Adults who received 3 doses of COVID-19 vaccine were 94% less likely to be put on a ventilator or die from COVID-19 compared to adults who were not vaccinatedllustration accompanying: Tenforde MW, Self WH, Gaglani M, et al. Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, ...
    Public Domain
  • Effectiveness of 2Dose BNT162b2 Pfizer BioNTech mRNA Vaccine in Preventing SARSCoV2 Infection Among Children Aged 511 Years and Adolescents Aged 1215 Years PROTECT Cohort July 2021February 2022
    Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
    Fowlkes, Ashley L. ;
    Yoon, Sarang K.
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDC's Advisory Committee on Immunization Practices for persons aged 12-15 years (referred to as adolescents in this report) on May 12, 2021, and for children aged 5-11 years on November 2, 2021 (1-4). Real-world data on vaccine effectiveness (VE) in these age groups are needed, ...
    Supporting Files Public Domain
  • COVID19associated Hospitalizations Among Adults During SARSCoV2 Delta and Omicron Variants Predominance by Raceethnicity and Vaccination Status COVIDNET 14 States July 2021January 2022
    COVID-19–associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variants Predominance, by Race/ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
    Taylor, Christopher A. ;
    Whitaker, Michael
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? SARS-CoV-2 infections can result in COVID-19–associated hospitalizations, even among vaccinated persons.What is added by this report? In January 2022, unvaccinated adults and those vaccinated with a primary series, but no booster or additional dose, were 12 and three times as likely to be hospitalized, respec ...
    Supporting Files Public Domain
  • Effectiveness of MRNA Vaccination in Preventing COVID19associated Invasive Mechanical Ventilation and Death United States March 2021January 2022
    Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
    Tenforde, Mark W. ;
    Self, Wesley H.
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? COVID-19 mRNA vaccines provide protection against COVID-19 hospitalization among adults. However, how well mRNA vaccines protect against the most severe outcomes of COVID-19–related illness, including use of invasive mechanical ventilation (IMV) or death, is uncertain.What is added by this report? Receiving 2 ...
    Supporting Files Public Domain
  • During the Peak of Omicron COVID19 Hospitalization Rates in Black Adults Were Nearly 4x as High as Rates Among White Adults
    During the Peak of Omicron, COVID-19 Hospitalization Rates in Black Adults Were Nearly 4x as High as Rates Among White Adults
    Centers for Disease Control and Prevention (U.S.)
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Improving access to and confidence in vaccinations is needed to reduce this disparity.llustration accompanying: Taylor CA, Whitaker M, Anglin O, et al. COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022. M ...
    Public Domain
  • Tobacco Product Use Among Adults United States 2020
    Tobacco Product Use Among Adults - United States, 2020
    Cornelius, Monica E. ;
    Loretan, Caitlin G.
    2022/03/18 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Although cigarette smoking has declined over the past several decades, a diverse landscape of combustible and noncombustible tobacco products has emerged in the United States (1-4). To assess recent national estimates of commercial tobacco product use among U.S. adults aged ≥18 years, CDC analyzed data from the 2020 National Health Interview Survey ...
    Supporting Files Public Domain
  • Hospitalization of Infants and Children Aged 04 Years with Laboratoryconfirmed COVID19 COVIDNET 14 States March 2020February 2022
    Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
    Marks, Kristin J. ;
    Whitaker, Michael
    March 15, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? COVID-19 can cause severe illness in infants and children, including those aged 0–4 years who are not yet eligible for COVID-19 vaccination.What is added by this report? During Omicron Variants predominance beginning in late December 2021, U.S. infants and children aged 0–4 years were hospitalized at approxim ...
    Supporting Files Public Domain
  • COVID19 Hospitalization Rates Among Children Ages 4 and Younger Were 5x as High During the Peak of Omicron Compared with Delta
    COVID-19 Hospitalization Rates Among Children Ages 4 and Younger Were 5x as High During the Peak of Omicron Compared with Delta.
    Centers for Disease Control and Prevention (U.S.)
    March 15, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Get vaccinated to help protecty yourself and those too young to be vaccinated.llustration accompanying: Marks KJ, Whitaker M, Agathis NT, et al. Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. MMWR Morb Mortal Wkly Rep. ePub: 15 March 2022.mm7111e2_Pediatric ...
    Public Domain
  • Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDCSponsored Investigational New Drug Program for Treatment of Chagas Disease US 20012021
    Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — U.S. 2001–2021
    Abbott, Andrew ;
    Montgomery, Susan P.
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Chagas disease, or American trypanosomiasis, is caused by the parasite Trypanosoma cruzi. Chagas disease is endemic in rural areas of Latin America, but T. cruzi, triatomine vectors, infected mammalian reservoir hosts, and rare cases of autochthonous vector borne Transmission have been reported in the U.S. (1). Possible modes of Transmission includ ...
    Supporting Files Public Domain
  • SARSCoV2 Incidence in K12 School Districts with MaskRequired Versus MaskOptional Policies Arkansas AugustOctober 2021
    SARS-CoV-2 Incidence in K–12 School Districts with Mask-Required Versus Mask-Optional Policies — Arkansas, August–October 2021
    Donovan, Catherine V. ;
    Rose, Charles
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Masks are effective at limiting Transmission of SARS-CoV-2, the Virus that causes COVID-19 (1), but the impact of policies requiring masks in school settings has not been widely evaluated (2-4). During fall 2021, some school districts in Arkansas implemented policies requiring masks for students in kindergarten through grade 12 (K-12). To identify ...
    Supporting Files Public Domain
  • Evaluation of Serologic CrossReactivity Between Dengue Virus and SARSCoV2 in Patients with Acute Febrile Illness United States and Puerto Rico April 2020March 2021
    Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness — United States and Puerto Rico, April 2020–March 2021
    Munoz-Jordan, Jorge ;
    Cardona, Jaime
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The Diagnosis of dengue disease, caused by the dengue Virus (DENV) (a flaviVirus), often requires serologic tTesting during acute and early convalescent phases of the disease. Some symptoms of DENV infection, such as nonspecific fever, are similar to those caused by infection with SARS-CoV-2, the Virus that causes COVID-19. In studies with few COVI ...
    Supporting Files Public Domain
  • Interim Estimates of 202122 Seasonal Influenza Vaccine Effectiveness United States February 2022
    Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
    Chung, Jessie R. ;
    Kim, Sara S.
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months except when contraindicated (1). Currently available influenza vaccines are designed to protect against four influenza Viruses: A(H1N1)pdm09 (the 2009 pandemic Virus), A(H3N2), B/Victoria lineage, and B/Yamagata lineage. Most influenza ...
    Supporting Files Public Domain
  • QuickStats Percentage of Adults Aged 18 Years Who Sleep 7 Hours On Average in a 24Hour Period by Sex and Age Group National Health Interview Survey US 2020
    QuickStats: Percentage of Adults Aged ≥18 Years Who Sleep <7 Hours On Average in a 24-Hour Period, by Sex and Age Group — National Health Interview Survey, U.S. 2020
    Adjaye-Gbewonyo, Dzifa ;
    Ng, Amanda E.
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Overall, 28.3% of men and 27.2% of women aged ≥18 years slept <7 hours on average within a 24-hour period. Among persons aged 18–44 years, men (28.8%) were more likely to sleep <7 hours compared with women (25.6%). Among adults aged 45–64 years, the percentage was similar for men (31.1%) and women (30.7%). However, among those aged ≥65 years, women (25.5%) were more likely than men (22.6%) to sleep <7 hours.Source: National Center for Health Statistics, National Health Interview Survey, 2020. https://www.cdc.gov/nchs/nhis/index.htmReported by: Dzifa Adjaye-Gbewonyo, PhD; Amanda E. Ng, MPH; Lindsey I. Black, MPH.
    Supporting Files Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 71 No 10 March 11 2022
    MMWR. Morbidity and Mortality Weekly Report, Vol. 71, No. 10, March 11, 2022
    Centers for Disease Control and Prevention (U.S.)
    03/11/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — U.S. February 2022 /Jessie R. Chung; Sara S. Kim; Rebecca J. Kondor; Catherine Smith et al. — Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — U.S. 2001–2021 ...
    Public Domain
  • Supplementary tables for COVID19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 511 years US November 2021January 2022
    Supplementary tables for: COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 years — U.S. November 2021–January 2022
    Centers for Disease Control and Prevention (U.S.)
    03/11/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Suppl.ementary tables for: Kim C, Yee R, Bhatkoti R, et al. COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — U.S. November 2021–January 2022. MMWR Morb Mortal Wkly Rep 2022;71:378–383.
    Public Domain
  • COVID19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 511 Years United States November 2021January 2022
    COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022
    Kim, Christine ;
    Yee, Randy
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On October 29, 2021, the Pfizer-BioNTech pediatric COVID-19 vaccine received Emergency Use Authorization for children aged 5-11 years in the United States| For a successful immunization program, both access to and uptake of the vaccine are needed. Fifteen million doses were initially made available to pediatric providers to ensure the broadest poss ...
    Supporting Files Public Domain
  • Morbidity and Mortality Weekly Report MMWR Surveillance Summaries March 2022 Vol 71 No SS5
    Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, March 2022 / Vol. 71 / No. SS-5
    Gentzke, Andrea S. ;
    Wang, Teresa W.
    03/11/2022 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    Commercial tobacco use is the leading cause of preventable disease, disability, and death in the United States. Most tobacco product use begins during adolescence. In recent years, tobacco products have evolved to include various combusted, smokeless, and electronic products. The National Youth Tobacco Survey (NYTS) is an annual, cross-sectional, s ...
    Supporting Files Public Domain
  • Notes From the Field Congenital Varicella Syndrome Case Illinois 2021
    Notes From the Field: Congenital Varicella Syndrome Case — Illinois, 2021
    Leung, Jessica ;
    Reid, Heather D.
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
921 - 940 / 9550
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov